Michael Thompson
Tempus Labs

Last Updated On 4/6/2023 11:34:36 AM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.

Employment
Company: Tempus
Recipient: You
Company: Aurora Health Care
Recipient: You

Leadership
No Relationships to Disclose

Stock and Other Ownership Interests
Company: Doximity
Recipient: You
Company: Tempus
Recipient: You

Honoraria
No Relationships to Disclose

Consulting or Advisory Role
Company: Celgene
Recipient: You
Company: VIA Oncology
Recipient: You
Company: Takeda
Recipient: You
Company: Syapse Precision Medicine Council
Recipient: You
Company: Adaptive Biotechnologies
Recipient: You
Company: Epizyme
Recipient: You
Company: Janssen Oncology
Recipient: You
Company: Sanofi
Recipient: You

Speakers' Bureau
No Relationships to Disclose

Research Funding
Company: Takeda
Recipient: Your Institution
Company: Bristol-Myers Squibb
Recipient: Your Institution
Company: TG Therapeutics
Recipient: Your Institution
Company: Abbvie
Recipient: Your Institution
Company: PrECOG
Recipient: Your Institution
Company: Strata Oncology
Recipient: Your Institution
Company: Lynx Biosciences
Recipient: Your Institution
Company: Denovo Biopharma
Recipient: Your Institution
Company: ARMO BioSciences
Recipient: Your Institution
Company: GSK
Recipient: Your Institution
Company: Amgen
Recipient: Your Institution

Patents, Royalties, Other Intellectual Property
Please describe: UpToDate, Peer Review for Plasma Cell Dyscrasias (Editor: Robert Kyle)
Recipient: You

Expert Testimony
No Relationships to Disclose

Travel, Accommodations, Expenses
No Relationships to Disclose

Other Relationship
Company: Doximity
Recipient: You

(OPTIONAL) Uncompensated Relationships
No Relationships to Disclose

(OPTIONAL) Open Payments Link
Open Payments URL: https://openpaymentsdata.cms.gov/physician/192826/summary